Metformin-induced TTP mediates communication between Kupffer cells and hepatocytes to alleviate hepatic steatosis by regulating lipophagy and necroptosisopen access
- Authors
- Park, J.; Rah, S.-Y.; An, H.S.; Lee, J.Y.; Roh, G.S.; Ryter, S.W.; Park, J.W.; Yang, C.H.; Surh, Y.-J.; Kim, U.-H.; Chung, H.T.; Joe, Y.
- Issue Date
- Apr-2023
- Publisher
- Elsevier BV
- Keywords
- Hepatocytes; Kupffer cells; Lipophagy; Metformin; Necroptosis; Non-alcoholic fatty liver disease; Sirt1; Tristetraprolin
- Citation
- Metabolism: Clinical and Experimental, v.141
- Indexed
- SCIE
SCOPUS
- Journal Title
- Metabolism: Clinical and Experimental
- Volume
- 141
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/30152
- DOI
- 10.1016/j.metabol.2023.155516
- ISSN
- 0026-0495
1532-8600
- Abstract
- Objective: Emerging evidence suggests that crosstalk between Kupffer cells (KCs) and hepatocytes protects against non-alcoholic fatty liver disease (NAFLD). However, the underlying mechanisms that lead to the reduction of steatosis in NAFLD remain obscure. Methods: Ttp+/+ and Ttp−/− mice were fed with a high-fat diet. Hepatic steatosis was analyzed by Nile Red staining and measurement of inflammatory cytokines. Lipid accumulation and cell death were evaluated in co-culture systems with primary hepatocytes and KCs derived from either Ttp+/+ or Ttp−/− mice. Results: Tristetraprolin (TTP), an mRNA binding protein, was essential for the protective effects of metformin in NAFLD. Metformin activated TTP via the AMPK-Sirt1 pathway in hepatocytes and KCs. TTP inhibited TNF-α production in KCs, which in turn decreased hepatocyte necroptosis. Downregulation of Rheb expression by TTP promoted hepatocyte lipophagy via mTORC1 inhibition and increased nuclear translocation of transcription factor-EB (TFEB). Consistently, TTP-deficient NAFLD mice failed to respond to metformin with respect to alleviation of hepatic steatosis, protection of hepatocyte necroptosis, or induction of lipophagy. Conclusions: TTP, which is essential for the protective effects of metformin, may represent a novel primary therapeutic target in NAFLD. © 2023
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.gnu.ac.kr/handle/sw.gnu/30152)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.